July 29, 2010

Does Folotyn® work in NSCLC? Allos Therapeutics Reports Phase 2 Results

On Wednesday the 28th Allos announced the results of their randomized phase 2 study comparing Folotyn

July 12, 2010

Buying Opportunities? Dendreon; Antisoma

On July 1st CMS announced that Dendreon’s Provenge® will undergo a National Coverage Determination (NCD).